Aesthetic Injectables Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Aesthetic Injectables Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Aesthetic Injectables pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Aesthetic Injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance. Aesthetic Injectables achieve providing a more youthful appearance by increasing the volume of sunken cheeks or temples, reducing lines around nose and mouth (marionette lines and smile lines), plumping up lips and enhancing facial contour.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Aesthetic Injectables under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Aesthetic Injectables and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Aesthetic Injectables under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
About GlobalData
Introduction
Aesthetic Injectables Overview
Products under Development
Aesthetic Injectables - Pipeline Products by Stage of Development
Table Figure 1: Aesthetic Injectables - Pipeline Products by Stage of Development
Table Aesthetic Injectables - Pipeline Products by Stage of Development
Aesthetic Injectables - Pipeline Products by Segment
Table Figure 2: Aesthetic Injectables - Pipeline Products by Segment
Table Aesthetic Injectables - Pipeline Products by Segment
Aesthetic Injectables - Pipeline Products by Territory
Table Figure 3: Aesthetic Injectables - Pipeline Products by Territory
Table Aesthetic Injectables - Pipeline Products by Territory
Aesthetic Injectables - Pipeline Products by Regulatory Path
Table Algeness VL - A Pivotal Clinical Study to Evaluate the Effectiveness and Safety of Algeness VL for the Correction of Moderate to Severe Nasolabial Folds
Table Algeness VL - A Prospective, Multi-center, Randomized, Controlled, Single-blind Study of the Safety and Effectiveness of Algeness DF 3.5% Deep Volumizing Filler to Correct Age-related Volume Deficit in the Mid-face
Table Juvederm Voluma Global - Malar Augmentation - Clinical, Instrumental and Histological Evaluation of the Combined Use of Onabotulinumtoxin A and Hyaluronic Acid Fillers in Patients with Facial Paralysis
Table Saypha Volume Plus Lidocaine - A Randomized, Multi-center, Evaluator-blinded, Parallel Assignment, Active Controlled Study to Evaluate the Efficacy and Safety of Princess Voluma plus and Restylane Perlane Lidocaine for Correction of Midface Volume Deficit And/Or Midface Contour Deficiency
Table KIO015 Intradermal Injectable Device - A Randomized, Controlled, Split-Face Study to Evaluate the Clinical Performance and Safety of KIO015 for Improving Face Skin Hydration
Table IPN-21-SENSE Dermal Filler - A Multicenter, Prospective, Randomized Controlled Clinical Study of IPN-21-SENSE, a Novel Hyaluronic Acid Based Gel for Volume Deficiency in the Mid-face
LG Chem Ltd Company Overview
LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Next Generation Hyaluronic Acid Filler (LR20008) - Product Status
Table Next Generation Hyaluronic Acid Filler (LR20008) - Product Description
Table YVOIRE Y-Solution 360 - Product Status
Table YVOIRE Y-Solution 360 - Product Description
Table YVOIRE Y-Solution 540 - Product Status
Table YVOIRE Y-Solution 540 - Product Description
Table YVOIRE Y-Solution 720 - Product Status
Table YVOIRE Y-Solution 720 - Product Description
Table LG Chem Ltd - Ongoing Clinical Trials Overview
Table YVOIRE Y-Solution 360 - A Multicenter, Randomized, Rater-Blinded, No-Treatment Control Design Clinical Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 360 for Lip Augmentation
Table YVOIRE Y-Solution 540 - A Randomized, Multicenter, Evaluator-blinded, Active-controlled, Parallel-group Design Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 540 Versus YVOIRE Volume Plus in Nasolabial Folds Injection
Table Lumina - A Prospective, Randomized, Controlled, Multi-center Study of the Safety and Effectiveness of Lumina in the Treatment of Nasolabial Folds
Table Lafullen Dermal Filler - A Randomized, Evaluator-blind, Matched Pairs, Prospective, Non Inferiority, Confirmatory Study to Compare the Safety and Efficacy Between Lafullen15 and Lafullen in the Correction of Nasolabial Folds
Table Ellanse Lidocaine - Prospective, Single Site, Controlled Comparative Study to Identify and Assess Tissue Responses After Injection With Various Biostimulatory Products
Table MaiLi Extreme - A Post Market Clinical Follow Up (PMCF) Study to Assess the Safety and Efficacy of MaiLi Volume and MaiLi Extreme in the Treatment of Temporal Hollowing, Mid-Face Volume Deficit, Jawline Ptosis, and Chin Retrusion
Sofregen Medical Inc Company Overview
Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Collagen-Based Dermal Filler - Product Status(Trylle Skin Health Inc)
Table Collagen-Based Dermal Filler - Product Description(Trylle Skin Health Inc)
University of California Santa Barbara Company Overview
University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview
Table University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview
Table Needle Free Injector - Product Status
Table Needle Free Injector - Product Description
University of Missouri Company Overview
University of Missouri Pipeline Products & Ongoing Clinical Trials Overview
Table University of Missouri Pipeline Products & Ongoing Clinical Trials Overview
Table Collagen-Based Dermal Filler - Product Status(University of Missouri)
Table Collagen-Based Dermal Filler - Product Description(University of Missouri)
Volumina Medical SA Company Overview
Volumina Medical SA Pipeline Products & Ongoing Clinical Trials Overview
Table Volumina Medical SA Pipeline Products & Ongoing Clinical Trials Overview
Table Adipearl - Product Status
Table Adipearl - Product Description
Table Volumina Medical SA - Ongoing Clinical Trials Overview
Table Adipearl - A Single-Arm Pilot Study to Evaluate the Safety of Adipearl Injection in the Subcutaneous Tissues of Adults
Table Adipearl - A Single-Arm, Prospective, Clinical Investigation Evaluating the Safety and Feasibility of Adipearl Implantation in the Face of Adult Subjects
Aesthetic Injectables- Recent Developments
Apr 08, 2024: CGBio Targets European Aesthetic Market, Unveils Suture `LUXX' and `EGF Skin Booster' for the First Time
Mar 25, 2024: CGBio Discovers a Breakthrough in "Cartilage" Regeneration, Demonstrates the Regenerative Capabilities of "Hyaluronic Acid Gel" for Cartilage
Mar 21, 2024: Allergan Aesthetics Continues to Champion Individuality, Drive Innovation and Lead with Integrity as It Hosts Expert Led Symposia at AMWC 2024
Mar 05, 2024: JUVEDERM VOLUMA XC For Temple Hollows Receives U.S. FDA Approval
Mar 05, 2024: JUVÉDERM VOLUMA XC For Temple Hollows Receives U.S. FDA Approval
Mar 04, 2024: Revance Therapeutics Announces Proposed $100M Share Offering
Mar 01, 2024: Evolus Announces Results from European Head-to-Head Filler Trial
Feb 27, 2024: Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
Feb 27, 2024: LG Chem to Raise 1 tln Won in Bond Sale
Feb 22, 2024: AbbVie Selling $15 Billion Bonds to Buy ImmunoGen, Cerevel
Feb 07, 2024: Galderma Launches `Next', a Ground-Breaking Trend Report That Unveils the Future of Aesthetics
Feb 05, 2024: AbbVie's Full Year 2023 Sees 6.4% Net Revenue Drop
Feb 02, 2024: Galderma Celebrates 25 Years of Excellence in Biostimulation With Sculptra at the 2024 IMCAS
Jan 22, 2024: Galderma Announces Regulatory Approval for Restylane SHAYPE, a new Hyaluronic Acid Injectable Designed for Augmenting the Chin Region
Jan 04, 2024: AbbVie to Host Full-Year and Fourth-Quarter 2023 Earnings Conference Call
Jan 03, 2024: Medytox Announces Executive Appointments in Luvantas, Inc
Nov 01, 2023: CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler
Oct 31, 2023: SKINVIVE by JUVEDERM Now Available from Dermatologist Dr. Ellen Turner
Oct 31, 2023: LG Chem Announces 3Q Management Performance
Oct 10, 2023: Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
Oct 04, 2023: AbbVie to Host Third-Quarter 2023 Earnings Conference Call
Sep 28, 2023: Merz Aesthetics Continues to Fuel Confidence by Expanding Belotero Balance (+) Filler Treatment Areas
Sep 19, 2023: Revance Provides Corporate Update at Investor Day
Aug 24, 2023: CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million
Aug 10, 2023: Medytox Appoints Director Kim Jae-wook to Oversee Medical Division
Aug 01, 2023: Allergan Aesthetics Announces First Ever JUVEDERM Day
Jun 26, 2023: Collplant Achieves Milestone and to Receive $10 Million From Abbvie in Accordance With Its Regenerative Dermal Filler Product Collaboration Agreement
Jun 12, 2023: Croma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China
May 30, 2023: Establishment labs announces CE mark approval for minimally invasive surgical tools
May 25, 2023: Samyang Holdings to supply 100 billion worth of its filler to China
May 15, 2023: SKINVIVE by JUVÉDERM receives U.S. FDA approval